Gender differences in the association of insulin resistance and high-sensitivity c-reactive protein in obese adolescents

Journal of Diabetes and Metabolic Disorders

Volumn 13, Issue 1, 2014, Pages

  Alemzadeh, Ramin ^a   Kichler, Jessica ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

c reactive protein; Diabetes; Dyslipidemia; Metabolic syndrome; Obesity

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CARDIOMETABOLIC RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FAT MASS; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PUBERTY; RETROSPECTIVE STUDY; SEX DIFFERENCE;

EID: 84908209325     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/2251-6581-13-35     Document Type: Article

References (46)

1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752. 10.1161/CIRCULATIONAHA.105.169404, 16157765.
2. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity in the metabolic syndrome in children and adolescents. N Eng J Med 2004, 350:2362-2374.
3. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006, 97(2A):3A-11A.
4. Kahn SE, Zinman B, Haffner SM, O'Neill MC, Kravitz BG, Yu D, Freed MI, Herman WH, Holman RR, Jones NP, Lachin JM, Viberti GC, . ADOPT Study Group Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 2006, 55:2357-2364. 10.2337/db06-0116, 16873701, ADOPT Study Group.
5. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N. C-reactive protein is an independent predictor of risk for development of diabetes in the West of Scotland coronary prevention study. Diabetes 2002, 51:1596-1600. 10.2337/diabetes.51.5.1596, 11978661.
6. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Eng J Med 2000, 342:836-843.
7. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Eng J Med 2004, 350:1387-1397.
8. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of c-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral artery disease. JAMA 2001, 285:2481-2485. 10.1001/jama.285.19.2481, 11368701.
9. Trayhurn P, Wood IS. Adipokines: inflammation and pleiotropic role of white adipose tissue. Br J Nutr 2004, 92:347-355. 10.1079/BJN20041213, 15469638.
10. Ford ES, Galuska DA, Gillespie C, Will JC, Giles WH, Dietz WH. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Pediatr 2001, 138:486-492. 10.1067/mpd.2001.112898, 11295710.
11. López-Jaramillo P, Herrera E, Garcia RG, Camacho PA, Castillo VR. Inter-relationships between body mass index, C-reactive protein and blood pressure in a Hispanic pediatric population. Am J Hypertens 2008, 21:527-532. 10.1038/ajh.2007.86, 18437144.
12. Apovian CM, Bigornia S, Mott M, Meyers MR, Ulloor J, Gagua M, McDonnell M, Hess D, Joseph L, Gokce N. Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol 2008, 28:1654-1659. 10.1161/ATVBAHA.108.170316, 2728436, 18566296.
13. Mauras N, Delgiorno C, Kollman C, Bird K, Morgan M, Sweeten S, Balagopal P, Damaso L. Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J Clin Endocrinol Metab 2010, 95:1060-1068. 10.1210/jc.2009-1887, 20061420.
14. Jeppesen J, Hansen TW, Olsen MH, Rasmussen S, Ibsen H, Torp-Pedersen C, Hildebrandt PR, Madsbad S. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study. Eur J Cardiovasc Prev Rehabil 2008, 15:594-598. 10.1097/HJR.0b013e328308bb8b, 18753952.
15. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll of Cardiol 2007, 49:2129-2138.
16. Lindgarde F, Ercilla MB, Correa LR, Ahren B. Body adiposity, insulin, and leptin in subgroups of Peruvian Amerindians. High Alt Med Biol 2004, 5:27-31. 10.1089/152702904322963663, 15072714.
17. Freedman DS, Dietz WH, Tang R, Mensah GA, Bond MG, Urbina EM, Srinivasan S, Berenson GS. The relation of obesity throughout life to carotid intima-media thickness in adulthood: the Bogalusa Heart Study. Int J Obes Relat Metab Disord 2004, 28:159-166.
18. Järvisalo MJ, Harmoinen A, Hakanen M, Paakkunainen U, Viikari J, Hartiala J, Lehtimäki T, Simell O, Raitakari OT. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Artherioscler Thromb Vasc Biol 2002, 22:1323-1328.
19. Ross R. Atherosclerosis: an inflammatory disease. N Eng J Med 1999, 340:115-126.
20. Gonzales MA, Selwyn AP. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med 2003, 115(Suppl 8A):99S-106S.
21. Ford ES, Giles WH, Mokdad AH, Myers GL. Distribution and correlates of C-reactive protein concentrations among adult US women. Clin Chem 2004, 50:574-581. 10.1373/clinchem.2003.027359, 14709450.
22. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, Wians FH, Grundy SM, de Lemos JA. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005, 46:464-469. 10.1016/j.jacc.2005.04.051, 16053959.
23. Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D'Agostino RB, Herrington DM. Gender and C-reactive protein: data from the multiethnic study of Athersoclerosis (MESA) cohort. Am Heart J 2006, 152:593-598. 10.1016/j.ahj.2006.02.015, 16923436.
24. Khera A, Vega GL, Das SR, Ayers C, McGuire DK, Grundy SM, de Lemos JA. Sex differences in the relationship between c-reactive protein and body fat. J Clin Endocrinol Metab 2009, 94:3251-3258. 10.1210/jc.2008-2406, 2741708, 19567538.
25. Lai MM, Li CI, Kardia SLR, Liu CS, Lin WY, Lee YD, Chang PC, Lin CC, Li TC. Sex difference in the association of metabolic syndrome with high sensitivity c-reactive protein in a Taiwanese population. BMC Public Health 2010, 10:429-436. 10.1186/1471-2458-10-429, 2920887, 20663138.
26. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000, 320:1240-1243. 10.1136/bmj.320.7244.1240, 27365, 10797032.
27. Lommez A, Borys JM, Ducimetiere P, Charles MA. Reliability of bioimpedance analysis compared with other adiposity measurements in children: the FLVS II Study. Diabet Metab 2005, 31:534-541.
28. Lazzer S, Boirie Y, Meyer M, Vermorel M. Which alternative method to dual-energy X-ray absorptiometry for assessing body composition in overweight and obese adolescents?. Arch Pediatr 2005, 12:1094-1101. 10.1016/j.arcped.2005.03.040, 15964524.
29. Brasil AR, Norton RC, Rossetti MB, Leao E, Mendes RP. C-reactive protein as an indicator of low intensity inflammation in children and adolescents with and without obesity. J Pediatr (Rio J) 2007, 83:477-480.
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
31. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol without use of preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
32. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 2004, 114:555-576. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents.
33. Baron R, Kenny D. The moderador-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986, 51:1173-1182.
34. Sobel M. Asymptotic intervals for indirect effects in structural equation models. Sociological Methodology 1982, 290-312. San Francisco, CA: Jossey-Bass.
35. Gelaye B, Revilla L, Lopez T, Suarez L, Sanchez SE, Hevner K, Fitzpatrick AL, Williams MA. Association between insulin resistance and c-reactive protein among Peruvian Adults. Diabetology and Metabolic Syndrome 2010; 2: 30-36.diabetic patients. Diabetes Metab J 2011, 35:41-49. 10.4093/dmj.2011.35.1.41, 3080577, 21537412.
36. Meng YX, Ford ES, Li C, Quarshie A, Al-Mahmoud AM, Giles W, Gibbons GH, Strayhorn G. Association of c-reactive protein with surrogate measures of insulin resistance among nondiabetic US adults: Findings from National Health and Nutrition Examination Survey 1999-2002. Clin Chem 2007, 53:2152-2159. 10.1373/clinchem.2007.088930, 17951292.
37. Wang G, Christoffel KK, Brickman WJ, Hong X, Arguelles L, Zhang S, Wang B, Li Z, Xing H, Tang G, Zimmerman D, Xu X, Wang X. C-reactive protein in adolescent twins: Patterns and relationship to adiposity. J Clin Endocrinol Metab 2011, 96:3226-3233. 10.1210/jc.2011-0590, 3200237, 21832113.
38. Chen CH, Tsai ST, Chou P. Correlation of fasting serum C-peptide and insulin with markers of metabolic syndrome-X in a homogenous Chinese population with normal glucose tolerance. Int J Cardiol 1999, 68:179-186. 10.1016/S0167-5273(98)00366-0, 10189006.
39. Kim ST, Kim BJ, Lim DM, SongI G, Jung JH, Lee KW, Park KY, Cho YZ, Lee DH, Koh GP. Basal c-peptide level as a surrogate marker of subclinical atherosclerosis in type 2 diabetic patients. Diabetes Metab J 2011, 35:41-49. 10.4093/dmj.2011.35.1.41, 3080577, 21537412.
40. Patel N, Taveira TH, Choudhary G, Whitlatch H, Wu WC. Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults. J Am Heart Assoc 2012, 1(6):e003152. doi:10.1161/JAHA.112.003152, 3540682, 23316320.
41. Abdullah A, Hasan H, Raigangar V, Bani-Issa W. C-Peptide Versus Insulin: Relationships with risk biomarkers of cardiovascular disease in metabolic syndrome in young Arab females. Int J Endocrinol 2012, Article ID 420792, 5 pages; doi:10.1155/2012/420792.
42. Jiang X, Srinivasan SR, Radhakrishnamurthy B, Dalferes ER, Berenson GS. Racial (Black-White) Differences in Insulin Secretion and Clearance in Adolescents: The Bogalusa Heart Study. Pediatrics 1996, 97:357-360.
43. Lee CC, Lorenzo C, Haffner SM, Wagenknecht LE, Goodarzi MO, Stefanovski D, Norris JM, Rewers MJ, Hanley AJ. Components of metabolic syndrome and 5-year change in insulin clearance - the Insulin Resistance Atherosclerosis Study. Diabetes Obes Metab 2012, doi:10.1111/dom.12049.
44. Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 2009, 42:1331-1346. 10.1016/j.clinbiochem.2009.05.018, 19501581.
45. Lorenzo C, Hanley AJ, Wagenknecht LE, Rewers MJ, Stefanovski D, Goodarzi MO, Haffner SM. Relationship of insulin sensitivity, insulin secretion and adiposity with insulin clearance in a multiethnic population: the insulin resistance atherosclerosis study. Diabetes Care 2013, 36:101-103. 10.2337/dc12-0101, 3526225, 22933441.
46. Haroun D, Crocker H, Viner RM, Williams JE, Darch TS, Fewtrell MS Eaton S, Wells JC. Validation of BIA in obese children and adolescents and re-evaluation in a longitudinal study. Obesity 2009, 12:2245-2250.